Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker HAFC
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 29, 2026 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 27, 2026 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 17, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 11, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 31, 2026 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 31, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 31, 2026 | HAFC Hanmi Financial Corporation | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jul 31, 2026 | HAFC Hanmi Financial Corporation | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 27, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 23, 2026 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 21, 2026 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 28, 2026 | HAFC Hanmi Financial Corporation | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 28, 2026 | HAFC Hanmi Financial Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 1, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 23, 2026 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 21, 2026 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 24, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 3, 2026 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 29, 2026 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 27, 2026 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 14, 2025 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 24, 2025 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 21, 2025 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 30, 2025 | HAFC Hanmi Financial Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jul 29, 2025 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 24, 2025 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 22, 2025 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 28, 2025 | HAFC Hanmi Financial Corporation | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 6, 2025 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 24, 2025 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 22, 2025 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 11, 2025 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 5, 2025 | HAFC Hanmi Financial Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 3, 2025 | HAFC Hanmi Financial Corporation | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 20, 2025 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 29, 2025 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 28, 2025 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 28, 2025 | HAFC Hanmi Financial Corporation | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 18, 2024 | HAFC Hanmi Financial Corporation | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 24, 2024 | HAFC Hanmi Financial Corporation | 8.01 Other Events | 8-K | 8-K ↗ |
40 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:37 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances